Skip to Content
Merck
CN

V900144

Glycine

98%, Vetec

Synonym(s):

Aminoacetic acid, Aminoethanoic acid, Glycocoll

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Linear Formula:
NH2CH2COOH
CAS Number:
Molecular Weight:
75.07
UNSPSC Code:
12352209
PubChem Substance ID:
EC Number:
200-272-2
Beilstein/REAXYS Number:
635782
MDL number:
eCl@ss:
32160406
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Product Name

Glycine, Vetec, reagent grade, 98%

grade

reagent grade

product line

Vetec

assay

98%

form

powder

technique(s)

cell culture | plant: suitable

color

white to off-white

pH

5.9-6.4 (20 °C, 50 g/L)

pKa (25 °C)

(1) 2.35, (2) 9.60, 2.35

mp

240 °C (dec.) (lit.)

SMILES string

NCC(O)=O

InChI

1S/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5)

InChI key

DHMQDGOQFOQNFH-UHFFFAOYSA-N

Biochem/physiol Actions

Inhibitory neurotransmitter in spinal cord, allosteric regulator of NMDA receptors.

Legal Information

Vetec is a trademark of Merck KGaA, Darmstadt, Germany


Still not finding the right product?

Explore all of our products under Glycine


Storage Class

13 - Non Combustible Solids

wgk

WGK 1

flash_point_f

No data available

flash_point_c

No data available



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Bethany L Johnson-Kerner et al.
Human molecular genetics, 24(5), 1420-1431 (2014-11-16)
Giant axonal neuropathy (GAN) is a progressive neurodegenerative disease caused by autosomal recessive mutations in the GAN gene resulting in a loss of a ubiquitously expressed protein, gigaxonin. Gene replacement therapy is a promising strategy for treatment of the disease;
M E Lindholm et al.
American journal of physiology. Regulatory, integrative and comparative physiology, 307(3), R248-R255 (2014-06-06)
The transcription factor hypoxia-inducible factor (HIF) has been suggested as a candidate for mediating training adaptation in skeletal muscle. However, recent evidence rather associates HIF attenuation with a trained phenotype. For example, a muscle-specific HIF deletion increases endurance performance, partly
Stanley Adoro et al.
Nature communications, 6, 7562-7562 (2015-06-26)
Initial events after exposure determine HIV-1 disease progression, underscoring a critical need to understand host mechanisms that interfere with initial viral replication. Although associated with chronic HIV-1 control, it is not known whether interleukin-21 (IL-21) contributes to early HIV-1 immunity.



Global Trade Item Number

SKUGTIN
V900144-500G04061837481536
V900144-6X500G04061835550562